Remdesivir Found To Reduce Hospitalization Of Patients With COVID-19 By 87%

Bloomberg (9/22, Gale) reports, “Early treatment with Gilead Sciences Inc.’s remdesivir kept high-risk Covid-19 patients out of the hospital in a late-stage international trial that supports administering the medicine to individuals recovering at home.” A...